ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GRTS

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Gritstone bio, Inc. securities between March 9, 2023, and February 29, 2024, of the August 6, 2024, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - A class action lawsuit has been filed against Gritstone bio, Inc. for allegedly making false and misleading statements regarding its COVID-19 vaccine candidate and its ability to launch the Phase 2b CORAL Study [9]. - Investors who purchased Gritstone securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [8]. - The lawsuit claims that Gritstone overstated its ability to develop and commercialize its products, leading to investor damages when the true details were revealed [9]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [2]. - Until a class is certified, investors are not represented by counsel unless they retain one, and they may choose to remain absent from the class [3]. - To serve as lead plaintiff, investors must file a motion with the court by August 6, 2024 [4].